SCHOFIELD, Wis., Dec. 1, 2009 (GLOBE NEWSWIRE) -- PuraMed BioScience (OTCBB:PMBS), a pharmaceutical company engaged in the development and marketing of a line of revolutionary, new, non-prescription medicines that treat migraine headaches, insomnia and tension-type headaches under the brand name LipiGesic(TM), announced today that it has recently secured funding through a private placement in the amount of $500,000, the largest amount to date, which will allow the Company to initiate further efforts to reach its goals and objectives as outlined in its business plan.
